GT19630

PROTAC c-Myc degrader-1 (Compound A153) is a multiple target protein degrader (PROTAC) . PROTAC c-Myc degrader-1 effective degrades c-MYC, CK1α, GSPT1 and IKZF1/2/3 proteins in a variety of tumor cells. PROTAC c-Myc degrader-1 can be used for c-Myc high expression related disease research, such as cancer, cardiovascular and cerebrovascular diseases, and viral infection (Pink: c-Myc ligand (HY-168685) ; Blue: E3 ligase ligand (HY-W093472) ; Black: linker (HY-W015808) ) [1].

Product Specifications

CAS Number

[2883535-99-5]

UNSPSC

12352005

Target

Casein Kinase; c-Myc; PROTACs

Type

Reference compound

Related Pathways

Apoptosis; Cell Cycle/DNA Damage; PROTAC; Stem Cell/Wnt

Applications

COVID-19-anti-virus

Field of Research

Cancer; Infection; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/c-myc-inhibitor-7.html

Purity

98.85

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(C1=CC=C2C(N(C3C(NC(CC3)=O)=O)CC2=C1)=O)NCC4=CC=C(CNC(CN5C6=C(C7=CC=CC=C75)C=CC=N6)=O)C=C4

Molecular Formula

C35H30N6O5

Molecular Weight

614.65

References & Citations

[1]TONG YOUZHI, et al. 2,6-Dioxopiperidine compounds as c-Myc inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. WO2022268066. 2022.